drugset
drugset / Trial / NCT00574743

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients

NCT00574743 ↗

Phase 4 Completed 162 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will evaluate the safety and efficacy of EC-MPS (ERL080) in comparison to MMF in de novo heart recipients.

Timeline

Start
2002-01
Primary completion
2004-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mycophenolate Sodium Unknown — —

Indications

No indication recorded.